NDC 54092-0100-01
MESALAMINE 1.2 g/1 TABLET, DELAYED RELEASE
Available — 2-Day Shipping
NDC
54092-0100-01
Generic Name
MESALAMINE
Brand Name
Mesalamine
Strength
1.2 g/1
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Package Size
—
Labeler
Takeda Pharmaceuticals America, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Mesalamine delayed-release tablets are indicated for the: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg. Mesalamine delayed-release tablets are an aminosalicylate indicated for the: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. ( 1 ) treatmen…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All MESALAMINE Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other MESALAMINE NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 54092-0100-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).